Journal of Molecular Canceris an open access, peer reviewed, scholarly journal that aims to enhance our understanding on the genesis, diagnosis, consequences of cancer molecules by critiquing the literature on Molecular Cancer, Cell and Tumor Biology, Angiogenesis, Cancer Antigens, Cellular Signaling ...
过去5年,International Journal of Cancer杂志的自引率均在5%以下,2021年度的最新自引率为1.4%,无自引风险。 往年对International Journal of Cancer引用次数较多的期刊,主要有:Cancers、Frontiers in Oncology、International Journal of Molecular Sciences、Cells、Scientific Reports、Cancer Medicine等,其中的Cells(低危)...
Molecular Cancer(IF37.3),影响因子大幅扩张 Journal of Hematology & Oncology(IF28.5),连涨不断 而肿瘤免疫治疗领域的新锐JITC(IF10.9)也是榜上有名,甚至被调侃为:逐渐变成大佬的后花园。真实情况真的是这样吗? Journal for ImmunoTherapy of Cancer(简称JITC)旨在丰富交流内容,促进对快速发展的肿瘤免疫学和癌症免疫...
(7)肿瘤研究领域近年来开挂的Molecular Cancer杂志影响因子继去年刷新纪录达到历史最高41.444,今年略下降至37.3。 3. BPG出版社旗下七本SCIE收录期刊 (1)World Journal of Gastroenterology,其影响因子逐渐增加3.411,3.665,5.742,5.347,今年小幅跌至4.3; (2)World Journal of Stem Cells去年达到5.247,今年小幅回落至4...
2011201220132014201520162017Cancer ResearchOncology The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third...
《分子诊断杂志》(Journal Of Molecular Diagnostics)是一本以医学-病理学综合研究为特色的国际期刊。该刊由Elsevier Inc.出版商创刊于1999年,刊期Bimonthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-病理学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信...
期刊41:Journal of Cancer 影响因子:3.9 预警等级:2021中科院国际期刊中度预警;多地黑名单预警(2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、吉林大学第一医院、中山大学附属第一医院、徐州医科大学、长江大学高风险预警) 年度|影响因子|发文量|自引率 ...
Journal of Cancer Research PubMed indexed journals, Impact Factor journals, Web of Science indexed journals, Medline indexed journals
Journal of Molecular Evolution focuses on deciphering features of molecular evolution and the processes related to these features. Publishes subfields such ...
Liquid biopsy-based technologies: a promising tool for biomarker identification in her2-low breast cancer patients for improved therapeutic outcomes Abstract: The molecular classification of breast cancer plays a pivotal role in developing personalized treatment strategies, with the aim of improving therapeut...